ENOVIS CORPORATION
Last · NYSE$18.57-0.42 (-2.21%)close · yahoo · 14h ago
Market cap$1.07B57.7M sh
P/E · TTM-0.9fwd 5.2 · eps -19.23 · loss
Beta1.48vs S&P 500
Div yield0.00%annual · TTM
52w range
$16.70$34.28
Volume1.1Msession
| Revenue | $2.3B |
|---|---|
| Operating income | $23.9M |
| Net income | $-10.0M |
| Free cash flow | $2.3M |
| Operating margin | 1.0% |
| Net margin | -0.4% |
| Return on equity | -0.7% |
| Period | TTM 2026-07-03 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-02-26
- Net Margin Sharply Negative
Red flags
- Net Margin Sharply Negative — Net margin -52.7%
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$0.77
Est. revenue
557.1M
Press & signals
- GlobeNewswire
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
- GlobeNewswire
Enovis Announces Second Quarter 2026 Results
- GlobeNewswire
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care